Drug General Information
Drug ID
DX8LA7
Drug Name
N-[1-(2S-Ethyl-4-oxo-tetrahydro-furan-3S-ylcarbamoyl)-2S-(1-methyl-cyclopentyl)-ethyl]-4-(2-fluoro-benzenesulfonylamino)-benzamide
Synonyms
CHEMBL515588
Indication Discovery agent Investigative [1587926]
Formula
C28H34FN3O6S
Canonical SMILES
CC[C@@H]1OCC(=O)[C@H]1NC(=O)[C@H](CC2(C)CCCC2)NC(=O)c3ccc(NS(=O)(=O)c4ccccc4F)cc3
InChI
InChI=1S/C28H34FN3O6S/c1-3-23-25(22(33)17-38-23)31-27(35)21(16-28(2)14-6-7-15-28)30-26(34)18-10-12-19(13-11-18)32-39(36,37)24-9-5-4-8-20(24)29/h4-5,8-13,21,23,25,32H,3,6-7,14-17H2,1-2H3,(H,30,34)(H,31,35)/t21-,23-,25+/m0/s1
InChIKey
ZTZJEMIITUQFII-UMXIMWEHSA-N
Target and Pathway
Target(s) Cathepsin K Target Info [1587926]
Cathepsin L Target Info [1587926]
KEGG Pathway Lysosome
Osteoclast differentiation
Toll-like receptor signaling pathway
Rheumatoid arthritishsa04142:Lysosome
Phagosome
Antigen processing and presentation
Proteoglycans in cancer
Rheumatoid arthritis
NetPath Pathway TGF_beta_Receptor Signaling Pathway
RANKL Signaling Pathway
IL2 Signaling PathwayNetPath_16:IL4 Signaling Pathway
Reactome Collagen degradation
Degradation of the extracellular matrix
Activation of Matrix Metalloproteinases
Trafficking and processing of endosomal TLR
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway
Assembly of collagen fibrils and other multimeric structures
MHC class II antigen presentation
WikiPathways RANKL/RANK Signaling Pathway
Osteoclast SignalingWP2572:Primary Focal Segmental Glomerulosclerosis FSGS
References
Ref 1587926URL: https://www.ebi.ac.uk/chembl/ The ChEMBL database in 2017
Ref 1587926URL: https://www.ebi.ac.uk/chembl/ The ChEMBL database in 2017

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.